Partner Spotlight | MOORE Clinical Research

Chapel Hill, NC (May 12, 2021)- Devana Solutions, LLC is pleased to announce their newest client-partnership with MOORE Clinical Research, a privately owned and operated multi-specialty research site specializing in Phase II-IV clinical trials. Founded in 2006, MOORE has completed over 500 clinical trials across their vast and diverse patient population at their three locations in the Tampa Bay area of Florida. Through years of experience and success, MOORE continues to innovate and improve their processes to adapt to the ever-changing clinical trials landscape.

MOORE’s forward-thinking leadership began looking into new technologies to help improve efficiencies around trial identification and management. Already armed with the RealTime CTMS platform, MOORE was introduced to Devana Solutions since the two tech companies have a seamless API-integration. Now, with the two platforms in place, MOORE is able to track trial opportunities from pre-award through trial completion, resulting in an abundance of reportable performance metrics to share with Sponsors and CROs.

“Moore Clinical Research is an excellent addition to our Devana Solutions’ client-partner, hyperCORE International. Moore and the entire hyperCORE super network, which is now over 100 sites worldwide, are able to leverage our Devana IGNITE & PROPEL platforms to rapidly mobilize in study startup and to mine robust analytics and reporting to ensure the organization remains one of the most predictable and reliable performers in the clinical trials industry,” said Barry Lake, CEO, and Co-Founder of Devana Solutions, LLC.

By leveraging Devana’s pioneering platforms, MOORE hopes to continue to increase their trial volume by expanding their capabilities into more therapeutic areas. After implementing Devana’s IGNITE platform, MOORE has already doubled their total number of feasibility requests and site qualification visits per month. With this increase, MOORE is well on their way to exceeding the goals set in place for 2021. Devana Solutions is looking forward to being a part of MOORE’s continued growth and success!


Founded in 2006, MOORE Clinical Research, Inc. is a privately owned and operated clinical trial site specializing and experienced in conducting multi-specialty Phase II-IV clinical trials. We have three site locations across the Tampa Bay area, each covering a large and diverse patient base.

Our staff comes with over 100 years of research experience collectively and has consistently demonstrated a record of quality, integrity, and reliability. Since our inception in 2006, our demonstrated track record puts MOORE Clinical Research at the forefront when it comes to integrity and accuracy in clinical research.

To learn more, please visit


Devana Solutions®, LLC is a cloud SaaS provider driven by a core belief that data transparency through technology is critical to the selection of the top-performing performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease.

Devana Solutions® flagship platform, Devana IGNITE, allows integrated site networks and research organizations to standardize workflows, particularly in study startup, across site functions while allowing for the capture and display of performance metrics for dashboarding and analytics beyond site CTMS. Devana PROPEL extends performance data transparency across Academic Research Institutions or an expanded network of owned and affiliated investigative sites. Devana IQ allows for sharing performance data and documents in real-time between investigative site and Sponsor or CRO stakeholders. To learn more, visit